Your browser doesn't support javascript.
loading
Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination.
Winter, Amy K; Martinez, Micaela E; Cutts, Felicity T; Moss, William J; Ferrari, Matt J; McKee, Amalie; Lessler, Justin; Hayford, Kyla; Wallinga, Jacco; Metcalf, C Jess E.
Afiliación
  • Winter AK; Department of Ecology and Evolutionary Biology, Princeton University, Princeton, New Jersey.
  • Martinez ME; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York.
  • Cutts FT; London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Moss WJ; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Ferrari MJ; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • McKee A; Center for Infectious Disease Dynamics, The Pennsylvania State University, State College, Pennsylvania.
  • Lessler J; Center for Infectious Disease Dynamics, The Pennsylvania State University, State College, Pennsylvania.
  • Hayford K; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Wallinga J; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Metcalf CJE; Netherlands National Institute for Public Health and the Environment, Bilthoven, Netherlands.
J Infect Dis ; 218(3): 355-364, 2018 07 02.
Article en En | MEDLINE | ID: mdl-29562334
Background: Control efforts for measles and rubella are intensifying globally. It becomes increasingly important to identify and reach remaining susceptible populations as elimination is approached. Methods: Serological surveys for measles and rubella can potentially measure susceptibility directly, but their use remains rare. In this study, using simulations, we outline key subtleties in interpretation associated with the dynamic context of age-specific immunity, highlighting how the patterns of immunity predicted from disease surveillance and vaccination coverage data may be misleading. Results: High-quality representative serosurveys could provide a more accurate assessment of immunity if challenges of conducting, analyzing, and interpreting them are overcome. We frame the core disease control and elimination questions that could be addressed by improved serological tools, discussing challenges and suggesting approaches to increase the feasibility and sustainability of the tool. Conclusions: Accounting for the dynamical context, serosurveys could play a key role in efforts to achieve and sustain elimination.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rubéola (Sarampión Alemán) / Virus de la Rubéola / Transmisión de Enfermedad Infecciosa / Erradicación de la Enfermedad / Sarampión / Virus del Sarampión / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: J Infect Dis Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rubéola (Sarampión Alemán) / Virus de la Rubéola / Transmisión de Enfermedad Infecciosa / Erradicación de la Enfermedad / Sarampión / Virus del Sarampión / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: J Infect Dis Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos